NCT03890406View on ClinicalTrials.gov

The Effect of Deep Neuromuscular Blockade on Requirement of Intravenous Anesthetic Agent

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

March 31, 2020

Conditions
LaparoscopyGeneral AnesthesiaNeuromuscular Blockade
Interventions
DRUG

Rocuronium: PTC(Post-tetanic count) 1~2

Deep neuromuscular blockade will be maintained using continuous infusion of rocuronium.

DRUG

Rocuronium: TOF(Train-of-four) 1~2

Moderate neuromuscular blockade will be maintained using continuous infusion of rocuronium.

Trial Locations (1)

13620

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT03890406 - The Effect of Deep Neuromuscular Blockade on Requirement of Intravenous Anesthetic Agent | Biotech Hunter | Biotech Hunter